Table 3.
Medications supplied by private community pharmacies according to different scenarios.
| Variables | Viral upper respiratory tract infection n (%) | Direct product request n (%) | Child with acute watery diarrhoea symptoms n (%) |
|---|---|---|---|
| Scenario | Scenario 1 | Scenario 2 | Scenario 3 |
| Total number of visits | 316 (100) | 317 (100) | 316 (100) |
|
Antibiotic offered at any level of requests* Yes No |
291 (92·1) 25 (7·9) |
267 (84·2) 50 (15·8) |
135 (42·7) 181 (57·3) |
| Number of different medicines supplied | |||
| 0 | 2 (0·6) | 50 (15·8) | 0 |
| 1-2 | 2 (0·6) | 253 (79·8) | 122 (38·6) |
| 3-4 | 97 (30·7) | 11 (3·5) | 147 (46·5) |
| 5-6 | 190 (60·1) | 3 (0·9) | 44 (13·9) |
| ≥7 | 25 (7·9) | 0 | 3 (0·9) |
| Median number of medicines [IQR] | 5 [4–6] | 1 [1–1] | 3 [2–4] |
| Categories of medicines dispensed | |||
| Total number individual types of medicines received | 1569 | 313 | 962 |
| Unlabelled medicines | 494 (31·5) | 7 (2·2) | 209 (21·7) |
| Antibiotics | 255 (16·3) | 267 (85·3) | 115 (12·0) |
| Antidiarrheals | 0 | 0 | 262 (27·2) |
| Analgesics/ antipyretics | 46 (2·9) | 3 (1·0) | 3 (0·3) |
| Antihistamines | 107 (6·8) | 5 (1·6) | 1 (0·1) |
| Antitussives | 199 (12·7) | 9 (2·9) | 0 |
| Steroids/ NSAIDS | 100 (6·4) | 5 (1·6) | 0 |
| Vitamin Supplements | 32 (2·0) | 0 | 191 (19·9) |
| Medications containing 2 or more drugs Others | 234 (14·9) 102 (6·5) | 13 (4·2) 4 (1·3) | 2 (0·2) 179 (18·6) |
|
Level of demand required to obtain antibiotic Level 1 Level 2 Level 3 Missing data |
n = 291 283 (97·3) 3 (1·0) 4 (1·4) 1 (0·3) |
Not Applicable |
N = 135 111 (82·2) 3 (2·2) 21 (15·6) |
| Types of antibiotics supplied⁎⁎ | n = 255 | n = 267 | n = 115 |
| Penicillins | 52(20·4) | 248 (92·9) | 5 (4·3) |
| Tetracyclines | 1(0·4) | 0 | 3 (2·6) |
| Cephalosporins | 118 (46·3) | 16 (6·0) | 3 (2·6) |
| Fluoroquinolones | 45(17·6) | 1 (0·4) | 3 (2·6) |
| Lincomycins | 5 (2·0) | 0 | 0 |
| Macrolides | 24 (9·4) | 1 (0·4) | 2 (1·7) |
| Sulfonamides | 4(1·6) | 0 | 73 (63·5) |
| Unknown antibiotics | 5(1·6) | 1(0·4) | 18 (15·7) |
⁎
Reported by patient actor (prior to study pharmacist verification)
⁎⁎
Purchased medicines verified by study pharmacist